NCT02146625View on ClinicalTrials.gov

Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

September 30, 2015

Conditions
Healthy
Interventions
DRUG

CJ-40002

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY